MRTX849
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for MRTX849, covering 2025-09-30 to 2026-07-23. Get the full timeline:
Most recent: Clinical Trial Update: Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10) [Phase 3]